KR20090029528A - Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food - Google Patents
Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food Download PDFInfo
- Publication number
- KR20090029528A KR20090029528A KR1020070094845A KR20070094845A KR20090029528A KR 20090029528 A KR20090029528 A KR 20090029528A KR 1020070094845 A KR1020070094845 A KR 1020070094845A KR 20070094845 A KR20070094845 A KR 20070094845A KR 20090029528 A KR20090029528 A KR 20090029528A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- red ginseng
- silk peptide
- powder
- mixing
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 61
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 235000013305 food Nutrition 0.000 title claims abstract description 14
- 241000208340 Araliaceae Species 0.000 title 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title 1
- 235000003140 Panax quinquefolius Nutrition 0.000 title 1
- 235000008434 ginseng Nutrition 0.000 title 1
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 69
- 238000000855 fermentation Methods 0.000 claims abstract description 57
- 230000004151 fermentation Effects 0.000 claims abstract description 57
- 239000000843 powder Substances 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 21
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910001873 dinitrogen Inorganic materials 0.000 claims abstract description 7
- 238000004108 freeze drying Methods 0.000 claims abstract 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 20
- 241000186660 Lactobacillus Species 0.000 claims description 16
- 229940039696 lactobacillus Drugs 0.000 claims description 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 241000235070 Saccharomyces Species 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 11
- 241000272525 Anas platyrhynchos Species 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 6
- 238000009489 vacuum treatment Methods 0.000 claims description 6
- 210000003679 cervix uteri Anatomy 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 26
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 25
- 239000000203 mixture Substances 0.000 abstract description 14
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 abstract description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract 2
- 238000010298 pulverizing process Methods 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 18
- 239000004310 lactic acid Substances 0.000 description 10
- 229960000448 lactic acid Drugs 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 235000005340 Asparagus officinalis Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000003416 Asparagus officinalis Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 241000234427 Asparagus Species 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229920000392 Zymosan Polymers 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- -1 organics Substances 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KVJHGPAAOUGYJX-UHFFFAOYSA-N 1,1,3,3-tetraethoxypropane Chemical compound CCOC(OCC)CC(OCC)OCC KVJHGPAAOUGYJX-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 241000272522 Anas Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002205 anti-dementic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229930188557 apratoxin Natural products 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000015155 buttermilk Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3571—Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 홍삼 및 실크펩타이드를 주재로 한 건강보조식품의 제조방법 및 그 건강보조식품에 관한 것으로, 더욱 상세하게는 홍삼 및 실크펩타이드에 각각 액상 발효액을 첨가하여 숙성 발효한 다음 혼합함으로써, 변질을 막아 장기간 보관할 수 있고 인체 소화흡수력을 대폭 촉진시 킬 수 있도록 한 홍삼 및 실크펩타이드를 주재로 한 건강 보조식품의 제조방법 및 그 건강 보조식품에 관한 것이다.The present invention relates to a method for producing a health supplement food based on red ginseng and silk peptides and to health supplements thereof, and more particularly, by adding liquid fermentation broth to red ginseng and silk peptides, aging and fermenting them, and then mixing them. The present invention relates to a manufacturing method of a health supplement based on red ginseng and silk peptides that can be prevented and stored for a long time and greatly promote human digestive absorption, and a health supplement thereof.
일반적으로 홍삼의 효능은 설명이 필요 없을 정도로 논문이나 임상실험 등을 통해 증명되었으며 전 세계적으로 애용되는 건강보조식품 중의 하나이다.In general, the efficacy of red ginseng has been proved through papers and clinical trials without explanation, and is one of the health supplements that are widely used around the world.
그리고 실크펩타이드는, 실크의 가는 실의 외피를 형성하고 있는 세리신이라는 물질을 가공공정을 통해 녹여 제거하고, 그 내부에 존재하는 피브로인이라는 단백질을 얻은 다음 각종 효소 등을 촉매로 하여 가수분해를 통해 얻어지는데, 이때 가수분해방법 및 잔류물을 여과하는 방법에 따라 아미노산의 조성 및 분자량에 차이가 나며 실크펩타이드 특유의 생리활성도 달라진다고 보고되고 있다.The silk peptide is obtained by dissolving and removing a substance called sericin, which forms the outer skin of silk thread through a processing process, obtaining a protein called fibroin present therein, and then obtaining a hydrolysis using various enzymes as a catalyst. At this time, the composition and molecular weight of the amino acid and the physiological activity of the silk peptide is also reported to vary depending on the hydrolysis method and the method of filtering the residue.
또한, 실크펩타이드는 인체 단백질의 구성요소인 다양한 아미노산과 그 아미노산의 결합체가 혼재된 물질로서 의약적 효능을 나타내는 높은 생리적 활성을 가지고 있으며, 현재까지 알려진 실크펩타이드의 의약적 용도는 혈당치 저하, 혈중 콜레스테롤 저하, 알코올대사 촉진효과, 항치매, 항산화 작용 등의 의약적 용도로 사용되고 있다.In addition, silk peptide has a high physiological activity exhibiting medicinal efficacy as a mixture of various amino acids and a combination of amino acids, which are components of human proteins, and the medicinal uses of silk peptides known to date include lowering blood sugar levels and blood cholesterol It is used for medicinal purposes such as lowering, alcohol metabolism promoting effect, anti-dementia, antioxidant action.
이처럼 홍삼 및 실크펩타이드는 활용가치가 높은 건강보조식품으로 알려져 있음에도 식물성 홍삼과 동물성 실크펩타이드를 이용한 건강보조식품을 쉽게 제조하지 못하는 것은, 실크펩타이드를 발효하지 않고 그대로 건강보조식품으로 제조할 경우 각 유기물을 구성하는 단백질의 영향이 쉽게 변질되고 장기간 보관할 수 없기 때문이다.Although red ginseng and silk peptides are known as health supplements with high utilization value, it is not easy to manufacture health supplements using vegetable red ginseng and animal silk peptides. This is because the effects of the proteins that make up easily deteriorate and can not be stored for a long time.
그러나 이러한 문제는 식물성 홍삼과 동물성 실크펩타이드의 발효를 통해 쉽게 해결할 수 있으나, 그동안 홍삼과 같은 식물성 발효는 손쉽게 이루어지고 또한 관련 분야의 기술들이 많이 소개되고 있으나, 실크펩타이드와 같은 동물성 발효에 관련된 기술은 전무한 실정이다.However, this problem can be easily solved through fermentation of vegetable red ginseng and animal silk peptides. Meanwhile, while vegetable fermentation such as red ginseng is easily made and many technologies in related fields have been introduced, techniques related to animal fermentation such as silk peptides are There is no situation.
본 발명은 상기와 같은 기술적 과제를 해결하기 위해 발명된 것으로, 본 발명의 목적은 홍삼 및 실크펩타이드에 각각 액상 발효액을 첨가하여 숙성 발효한 다음 혼합함으로써, 장기간 보관할 수 있고 인체 소화흡수력을 대폭 촉진시 킬 수 있도록 한 홍삼 및 실크펩타이드를 주재로 한 건강 보조식품의 제조방법 및 그 건강 보조식품을 제공함에 그 목적이 있다.The present invention has been invented to solve the above technical problems, the object of the present invention is to add a liquid fermentation solution to the red ginseng and silk peptides, respectively, by fermentation and then fermented, and then mixed, can be stored for a long time and greatly promote human digestive absorption The purpose of the present invention is to provide a method of preparing a health supplement based on red ginseng and silk peptides and a health supplement thereof.
본 발명은 상기와 같은 기술적 과제를 해결하기 위해 발명된 것으로, 본 발명의 홍삼 및 실크펩타이드를 주재로 한 건강보조식품의 제조방법은 바실러스 서브틸리스, 사카로미세스 세르비제, 락토바실러스 아시도필루스, 아스파라기라스 오리제를 혼합하여 28~35℃ 상온에서 24~48시간 생육하여 액상 발효액을 제조하는 제1단계와; 제1단계의 액상 발효액을 진공처리 후 질소가스를 충진한 챔버에 저장하는 제2단계와; 홍삼을 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 홍삼분말을 제조하는 제3단계와: 홍삼분말 50중량%에 발효액 50중량%를 혼합하여 상온에서 7~10일간 홍삼분말을 발효하는 제4단계와; 실크펩타이드를 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 실크펩타이드분말을 제조하는 제5단계와; 실크펩타이드분말 25중량%에 발효액 75중량%를 혼합하여 상온에서 30~40일간 발효하는 제6단계와; 발효가 완료된 홍삼분말 60중량%에 발효가 완료된 실크펩타이드 40중량%를 혼합하여 완제품을 생산하는 제7단계를; 포함하여 이루어짐을 특징으로 한다.The present invention was invented to solve the above technical problem, the manufacturing method of the health supplement food based on the red ginseng and silk peptide of the present invention is Bacillus subtilis, Saccharomyces cervise, Lactobacillus asidofil A first step of preparing a liquid fermentation broth by mixing the loose and asparagus lyase and growing at 28 to 35 ° C. for 24 to 48 hours; A second step of storing the liquid fermentation broth of the first step in a chamber filled with nitrogen gas after vacuum treatment; Freeze-dried red ginseng and milled to 50 ~ 100 micron size step 3 to prepare a red ginseng powder: a fourth to ferment the red ginseng powder for 7 to 10 days at room temperature by mixing 50% by weight of fermented broth with 50% by weight red ginseng powder Steps; A fifth step of preparing a silk peptide powder by lyophilizing the silk peptide and grinding it to a size of 50 to 100 microns; A sixth step of fermenting the fermentation broth 75 wt% with 25 wt% of the silk peptide powder and fermenting at room temperature for 30-40 days; A seventh step of producing a finished product by mixing the fermentation completed with 60% by weight of red ginseng powder 40% by weight of the fermented silk peptide; It is characterized by including the.
또한, 상기 제1단계의 발효액은, 바실러스 서브틸리스 25중량%, 사카로미세스 세르비제 25중량%, 락토바실러스 아시도필루스 15중량%, 아스파라기라스 오리제를 잔부로 하여 이루어짐을 특징으로 한다.In addition, the fermentation broth of the first step, 25% by weight of Bacillus subtilis, 25% by weight of Saccharomyces cervise, 15% by weight of Lactobacillus asidophilus, characterized in that the balance asparagus duck do.
또한, 상기 제1단계의 발효액은, 바실러스 서브틸리스 25중량%, 사카로미세스 세르비제 25중량%, 락토바실러스 아시도필루스 15중량%, 아스파라기라스 오리제 25중량%, 스포어 10중량%를 혼합하여 이루어짐을 특징으로 한다.In addition, the fermentation broth of the first step, 25% by weight of Bacillus subtilis, 25% by weight of Saccharomyces cervis, 15% by weight of Lactobacillus asidophilus, 25% by weight of Asparagiras duck, 10% by weight of spores Characterized in that made by mixing.
또한, 본 발명의 홍삼 및 실크펩타이드를 주재로 한 건강보조식품은 바실러스 서브틸리스, 사카로미세스 세르비제, 락토바실러스 아시도필루스, 아스파라기라스 오리제를 혼합하여 28~35℃ 상온에서 24~48시간 생육하여 액상 발효액을 제조하는 제1단계와; 제1단계의 액상 발효액을 진공처리 후 질소가스를 충진한 챔버에 저장하는 제2단계와; 홍삼을 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 홍삼분말을 제조하는 제3단계와: 홍삼분말 50중량%에 발효액 50중량%를 혼합하여 상온에서 7~10일간 홍삼분말을 발효하는 제4단계와; 실크펩타이드를 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 실크펩타이드분말을 제조하는 제5단계와; 실크펩타이드분말 25중량%에 발효액 75중량%를 혼합하여 상온에서 30~40일간 발효하는 제6단계와; 발효가 완료된 홍삼분말 60중량%에 발효가 완료된 실크펩타이드 40중량%를 혼합하여 완제품을 생산하는 제7단계를; 포함하여 만들어짐을 특징으로 한다.In addition, the health supplement food based on the red ginseng and silk peptide of the present invention is a mixture of Bacillus subtilis, Saccharomyces cervix, Lactobacillus asidophyllus, Asparagiras duck, at a temperature of 28 ~ 35 ℃ 24 A first step of growing the liquid for 48 hours to prepare a liquid fermentation broth; A second step of storing the liquid fermentation broth of the first step in a chamber filled with nitrogen gas after vacuum treatment; Freeze-dried red ginseng and milled to 50 ~ 100 micron size step 3 to prepare a red ginseng powder: a fourth to ferment the red ginseng powder for 7 to 10 days at room temperature by mixing 50% by weight of fermented broth with 50% by weight red ginseng powder Steps; A fifth step of preparing a silk peptide powder by lyophilizing the silk peptide and grinding it to a size of 50 to 100 microns; A sixth step of fermenting the fermentation broth 75 wt% with 25 wt% of the silk peptide powder and fermenting at room temperature for 30-40 days; A seventh step of producing a finished product by mixing the fermentation completed with 60% by weight of red ginseng powder 40% by weight of the fermented silk peptide; It is characterized by including the made.
본 발명의 홍삼 및 실크펩타이트를 주재로 한 건강식품의 제조방법 및 건강식품은 다음과 같은 효과가 있다.Health food manufacturing method and health food based on the red ginseng and silk peptide of the present invention has the following effects.
1. 효모에 의한 발효라는 공정을 통해 제한적 유기용매 추출의 한계를 뛰어넘는 유효성분의 극대화를 이룰 수 있다.1. Through the process of fermentation by yeast, it is possible to maximize the active ingredient beyond the limit of limited organic solvent extraction.
2. 발효가 진행된 홍삼과 실크펩타이드가 저분자 구조로 분해되어 체내 흡수율을 극대화할 수 있다.2. Fermented red ginseng and silk peptides can be broken down into low molecular structure to maximize absorption in the body.
3. 생리활성물질이 풍부해 생체 이용률이 높고, 고유의 약효성분이 모두 유지하며 부작용이 거의 없을 뿐만 아니라 농약과 중금속으로부터 비교적 안전한 장점이 있다.3. It is rich in physiologically active substances, has high bioavailability, maintains all of its own active ingredients, has little side effects, and is relatively safe from pesticides and heavy metals.
4. 유효성분 집적으로 인한 제품의 단일화로 비타민, 유기물, 미네랄, 단백질이 풍부한 종합영양식품을 제공할 수 있다.4. It can provide a comprehensive nutrition rich in vitamins, organics, minerals and proteins by unifying the product by the accumulation of active ingredients.
5. 바쁜 현대인의 식생활을 개선하고 남녀노소 누구나 쉽고 간편하게 복용하며 어느 특화된 부분의 영양소가 아닌 종합적인 영양소를 공급할 수 있다.5. It can improve the diet of busy modern people and take it easy and convenient for everyone of all ages. It can supply comprehensive nutrition instead of specific nutrients.
6. 산성화된 체질을 약알칼리성으로 개선하여 면역체계를 활성화함으로써 동반되는 많은 부작용을 사전에 예방할 것으로 예상된다.6. It is expected that the acidified constitution will be weakly alkaline to prevent many side effects in advance by activating the immune system.
7. 동물성과 식물성이 혼합된 성분으로 편중되지 않는 고 함량 천연 단백질의 식품을 제공할 수 있다.7. It is possible to provide foods of high content of natural protein which are not biased by the mixture of animal and vegetable.
본 발명의 홍삼 및 실크펩타이드를 주재로 한 건강보조식품의 제조방법은 바실러스 서브틸리스, 사카로미세스 세르비제, 락토바실러스 아시도필루스, 아스파라기라스 오리제를 혼합하여 28~35℃ 상온에서 24~48시간 생육하여 액상 발효액을 제조하는 제1단계와; 제1단계의 액상 발효액을 진공처리 후 질소가스를 충진한 챔버에 저장하는 제2단계와; 홍삼을 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 홍삼분말을 제조하는 제3단계와: 홍삼분말 50중량%에 발효액 50중량%를 혼합하여 상온에서 7~10일간 홍삼분말을 발효하는 제4단계와; 실크펩타이드를 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 실크펩타이드분말을 제조하는 제5단계와; 실크펩타이드분말 25중량%에 발효액 75중량%를 혼합하여 상온에서 30~40일간 발효하는 제6단계와; 발효가 완료된 홍삼분말 60중량%에 발효가 완료된 실크펩타이드 40중량%를 혼합하여 완제품을 생산하는 제7단계를; 포함하여 이루어짐을 특징으로 한다.The manufacturing method of the health supplement food based on the red ginseng and silk peptide of the present invention is a mixture of Bacillus subtilis, Saccharomyces cervix, Lactobacillus asidophilus, Asparagus raisze at 28 ~ 35 ℃ room temperature Growing to 24 to 48 hours to produce a liquid fermentation broth; A second step of storing the liquid fermentation broth of the first step in a chamber filled with nitrogen gas after vacuum treatment; Freeze-dried red ginseng and milled to 50 ~ 100 micron size step 3 to prepare a red ginseng powder: a fourth to ferment the red ginseng powder for 7 to 10 days at room temperature by mixing 50% by weight of fermented broth with 50% by weight red ginseng powder Steps; A fifth step of preparing a silk peptide powder by lyophilizing the silk peptide and grinding it to a size of 50 to 100 microns; A sixth step of fermenting the fermentation broth 75 wt% with 25 wt% of the silk peptide powder and fermenting at room temperature for 30-40 days; A seventh step of producing a finished product by mixing the fermentation completed with 60% by weight of red ginseng powder 40% by weight of the fermented silk peptide; It is characterized by including the.
또한, 상기 제1단계의 발효액은, 바실러스 서브틸리스 25중량%, 사카로미세스 세르비제 25중량%, 락토바실러스 아시도필루스 15중량%, 아스파라기라스 오리제를 잔부로 하여 이루어짐을 특징으로 한다.In addition, the fermentation broth of the first step, 25% by weight of Bacillus subtilis, 25% by weight of Saccharomyces cervise, 15% by weight of Lactobacillus asidophilus, characterized in that the balance asparagus duck do.
또한, 상기 제1단계의 발효액은, 바실러스 서브틸리스 25중량%, 사카로미세스 세르비제 25중량%, 락토바실러스 아시도필루스 15중량%, 아스파라기라스 오리제 25중량%, 스포어 10중량%를 혼합하여 이루어짐을 특징으로 한다.In addition, the fermentation broth of the first step, 25% by weight of Bacillus subtilis, 25% by weight of Saccharomyces cervis, 15% by weight of Lactobacillus asidophilus, 25% by weight of Asparagiras duck, 10% by weight of spores Characterized in that made by mixing.
또한, 본 발명의 홍삼 및 실크펩타이드를 주재로 한 건강보조식품은 바실러스 서브틸리스, 사카로미세스 세르비제, 락토바실러스 아시도필루스, 아스파라기라 스 오리제를 혼합하여 28~35℃ 상온에서 24~48시간 생육하여 액상 발효액을 제조하는 제1단계와; 제1단계의 액상 발효액을 진공처리 후 질소가스를 충진한 챔버에 저장하는 제2단계와; 홍삼을 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 홍삼분말을 제조하는 제3단계와: 홍삼분말 50중량%에 발효액 50중량%를 혼합하여 상온에서 7~10일간 홍삼분말을 발효하는 제4단계와; 실크펩타이드를 동결 건조하고 이것을 50~100 미크론 크기로 분쇄하여 실크펩타이드분말을 제조하는 제5단계와; 실크펩타이드분말 25중량%에 발효액 75중량%를 혼합하여 상온에서 30~40일간 발효하는 제6단계와; 발효가 완료된 홍삼분말 60중량%에 발효가 완료된 실크펩타이드 40중량%를 혼합하여 완제품을 생산하는 제7단계를; 포함하여 만들어짐을 특징으로 한다.In addition, the health supplement foods based on the red ginseng and silk peptide of the present invention is a mixture of Bacillus subtilis, Saccharomyces cervix, Lactobacillus asidophilus, Asparagus ducks at 28 ~ 35 ℃ room temperature Growing to 24 to 48 hours to produce a liquid fermentation broth; A second step of storing the liquid fermentation broth of the first step in a chamber filled with nitrogen gas after vacuum treatment; Freeze-dried red ginseng and milled to 50 ~ 100 micron size step 3 to prepare a red ginseng powder: a fourth to ferment the red ginseng powder for 7 to 10 days at room temperature by mixing 50% by weight of fermented broth with 50% by weight red ginseng powder Steps; A fifth step of preparing a silk peptide powder by lyophilizing the silk peptide and grinding it to a size of 50 to 100 microns; A sixth step of fermenting the fermentation broth 75 wt% with 25 wt% of the silk peptide powder and fermenting at room temperature for 30-40 days; A seventh step of producing a finished product by mixing the fermentation completed with 60% by weight of red ginseng powder 40% by weight of the fermented silk peptide; It is characterized by including the made.
이하 첨부되는 도면을 참조하여 제조공정에 따라 본 발명을 설명하면 다음과 같다.Hereinafter, the present invention will be described according to the manufacturing process with reference to the accompanying drawings.
1) 제1단계: 액상 발효액 제조1) Step 1: Preparation of liquid fermentation broth
액상 발효액은 아래와 같은 효모의 구성 비율로 혼합하여 28~35℃의 상온에서 24~48시간 동안 생육하였다.The liquid fermentation broth was mixed at the composition ratio of the following yeast and grown for 24 to 48 hours at room temperature of 28 ~ 35 ℃.
액상 발효액 제조시 효모의 구성비Yeast Composition in Liquid Fermentation Broth
한편, 액상 발효액은 바실러스 서브틸리스 25 중량%, 사카로미세스 세르비제 25 중량%, 락토바실러스 아시도필루스 15 중량%, 아스파라기라스 오리제를 잔부로 하여 구성할 수도 있다.On the other hand, the liquid fermentation broth may be composed of 25% by weight of Bacillus subtilis, 25% by weight of Saccharomyces cervise, 15% by weight of Lactobacillus asidophilus, and asparagiras duck.
액상 발효액의 제조시 사용되는 액상 효모는, 열수추출 등의 방법에 의해 추출한 식용효모추출물을 주원료(고형분 함량으로 30% 이상)로 제조하였다. (단, 액상제품은 고형분으로 15% 이상)The liquid yeast used in the preparation of the liquid fermentation broth was prepared from edible yeast extract extracted by a method such as hot water extraction as a main raw material (30% or more in solid content). (However, liquid products have a solid content of 15% or more)
액상 발효액 제조시 사용된 각 액상효모의 효능과 기능을 살펴보면 다음과 같다.Looking at the efficacy and function of each liquid yeast used in the production of liquid fermentation broth are as follows.
맥주효모(Brewer's Yeast Brewer`sBrewer`s yeastyeast ))
맥주보리를 발아시켜 맥아즙을 만들고 홉(Hop)을 첨가한 추출액에 종균(Saccharomyces cerevisiae)을 넣어 배양하여 얻는다.Germination of beer barley to make wort and hops (Saccharomyces cerevisiae) is added to the extract (Hop) added to the culture obtained.
맥주효모는 고단백식품으로 소화흡수와 신체발육에 도움을 주며, 고단위 아 미노산 50%와 비타민 B군, 셀레늄(Se), GTF-크롬(Cr), 칼륨(K), 마그네슘(Mg) 등의 필수 미량원소인 미네랄 등이 함유되어 있다.Brewer's yeast is a high-protein food that helps digestion and physical development.It contains 50% high amino acid, vitamin B group, selenium (Se), GTF-chromium (Cr), potassium (K) and magnesium (Mg). It contains minerals, which are essential trace elements.
젖산효모Lactic acid yeast (( ProtibelProtibel yeastyeast ) )
Kluyveromyces Lactis와 Kluyveromyces flagilis라는 두 가지 효모균을 탈단백 탈지방화한 우유에 배양시켜 만들며, 아미노산 조성형태가 동물성과 유사하여, 핵산을 비롯하여 인(P), 나트륨(Na), 칼륨(K), 마그네슘(Mg) 등이 함유되어 있다.Two yeasts, Kluyveromyces Lactis and Kluyveromyces flagilis, are cultured in deproteinized defatted milk.The amino acid composition is similar to that of animal, and it contains nucleic acid, phosphorus (P), sodium (Na), potassium (K) and magnesium ( Mg) and the like.
청국장효모(Cheonggukjang Yeast bacillusbacillus subtilissubtilis ))
바실러스 서브틸러스균은 메주는 발효과정에서 발암물질인 아프라톡신이 100% 파괴되며, 메주를 띄울 때 발효과정에서 생기는 갈색의 끈적끈적한 물질 속에 새로운 항암 물질 바실러스 서브틸러스균이 생겨 이에 의하여 강력한 항암효과가 있다.Bacillus subtilis bacteria are 100% destroyed by carcinogenic apratoxin in meju fermentation process, and new anti-cancer substance Bacillus subtilis bacterium is formed in brown sticky substance produced during fermentation process. There is.
빵효모(Baker's yeast SaccharomycesSaccharomyces cerevisaecerevisae ))
빵효모는 질소화합물과 탄수화물로 되어있고, 이것은 균체의 배양환경이나 증식기에 따라 다르며, 빵효모 속의 탄수화물로서는 트레할로스나 글리코겐과 같이 에너지원이 될 수 있는 당과 글루칸이나 만난 등의 세포벽을 구성하는 다당체가 함유되어 있다.The baker's yeast is composed of nitrogen compounds and carbohydrates, and this depends on the culture environment and growth stage of the cells. The carbohydrates in baker's yeast are polysaccharides that make up cell walls such as sugar, glucan, and mannan that can be energy sources such as trehalose and glycogen. Contains.
빵효모는 건조 중량당 단백질 함량이 치즈보다 높고 그 아미노산조성을 동물 성 단백질과 비교해 볼 때 메티오닌의 함량이 약간 적은 점 이외에는 근단백이나 카제인과 상당히 흡사하여 영양학적으로 높이 평가되고 있는 식품이다.Baker's yeast is a food that is highly valued nutritionally, much like muscle protein or casein except that the protein content per dry weight is higher than that of cheese and its amino acid composition is slightly lower than that of animal protein.
젖산균(세균)(Lactic acid bacteria (bacteria) lacticlactic -- acidacid bacteriabacteria , 유산균), Lactobacillus)
탄수화물을 젖산으로 분해하는 여러 가지 세균들로서, 연쇄상구균속(Streptococcus), 젖산간균속(Lactobacillus), 류코노스토크속(Leuconostoc), 페디오코쿠스속(Pediococcus) 등이 있다.Various bacteria that break down carbohydrates into lactic acid include Streptococcus, Lactobacillus, Leuconostoc and Pediococcus.
몇몇 세균들은 피클, 사워크라우트, 녹색 올리브, 몇몇 소시지 종류, 버터밀크 같은 일부 유제품 등을 만드는 데 필요한 발효에 주로 쓰이며, 또한 면역기능을 향상시켜 각종 암이나, 바이러스 간염을 개선하는 작용이 있는 식물 다당체인 베타 글루칸(β-Glucan), 지모산(Zymosan) 등을 함유하고 있다.Some bacteria are used primarily for the fermentation needed to make pickles, sour loaf, green olives, some sausage varieties, and some dairy products such as buttermilk, as well as plant polysaccharides that work to improve immune function and improve cancer and viral hepatitis. Phosphorus beta glucan (β-Glucan), Zymosan (Zymosan) and the like.
2) 제2단계: 액상 발효액 저장2) second step: liquid fermentation broth storage
제1단계를 거친 액상 발효액은 진공처리 후 질소가스를 충진한 챔버에 저장하였고, 액상 발효액의 성분 구성비를 발효 50일 경과 후 측정한 결과 아래와 같은 데이터를 얻을 수 있었다.The liquid fermentation broth, which passed through the first step, was stored in a chamber filled with nitrogen gas after vacuum treatment, and the composition data of the liquid fermentation broth was measured after 50 days of fermentation.
발효성분 분석표Fermented Ingredients Analysis Table
3) 제3단계: 홍삼분말제조3) Step 3: Manufacture red ginseng powder
홍삼을 동결건조한 다음 50~100 미크론 크기로 분쇄하여 홍삼분말을 제조하였다.Red ginseng was lyophilized and ground to a size of 50-100 microns to prepare red ginseng powder.
4) 제4단계: 홍삼분말발효4th step: red ginseng powder fermentation
제3단계에서 제조된 홍삼분말 50중량%에 제1, 2단계에서 제조된 액상 발효액 50중량%를 혼합하여 상온에서 7~8일간 홍삼분말을 발효하였다.50% by weight of the red ginseng powder prepared in the third step was mixed with 50% by weight of the liquid fermentation broth prepared in the first and second steps to ferment the red ginseng powder at room temperature for 7-8 days.
발효 홍삼과 발효하지 않은 일반홍삼을 비교한 결과 다음과 같은 차이점이 있었다.The comparison between fermented red ginseng and non-fermented red ginseng showed the following differences.
또한, 발효 홍삼의 성분을 분석한 결과 아래 표의 결과와 같이 사포닌 함량은 증가하였고, 미생물 또한 전반적으로 증식하였음을 알 수 있었다.In addition, as a result of analyzing the components of fermented red ginseng saponin content was increased as shown in the table below, it can be seen that the microorganisms also overall growth.
▶홍삼의 성분함량▶ Content of Red Ginseng
▶미생물Microorganisms
5) 제5단계: 5) Step 5: 실크펩타이드분말제조Silk Peptide Powder Manufacturing
실크펩타이드를 동결 건조한 다음 50~100 미크론 크기로 분쇄하여 실크펩타이드 분말을 제조하였다.Silk peptides were freeze-dried and then ground to 50-100 micron size to prepare silk peptide powder.
6) 제6단계: 6) Step 6: 실크펩타이드분말발효Silk Peptide Powder Fermentation
제5단계에서 제조한 실크펩타이드분말 25중량%에 제1, 2단계에서 제조한 액상 발효액 75중량%를 혼합하여 상온에서 30~40일간 발효하였다.25 wt% of the silk peptide powder prepared in the fifth step was mixed with 75 wt% of the liquid fermentation broth prepared in the first and second steps and fermented at room temperature for 30 to 40 days.
발효 실크펩타이드 시료의 성분을 분석한 결과 아래와 같은 데이터를 얻을 수 있었다.As a result of analyzing the components of the fermented silk peptide sample, the following data was obtained.
▶▶ 실크펩타이드Silk Peptide 성분 ingredient
▶미생물Microorganisms
위 데이터를 통해 발효 실크펩타이드에는 성인병 예방, 치료에 관여하는 성분인 글리신, 알리닌, 세린, 아스파라긴산이 다량으로 함유되어 있음을 알 수 있었고 미생물의 또한 전반적으로 증식하였음을 알 수 있었다.The above data shows that fermented silk peptides contain glycine, alinine, serine, and aspartic acid, which are involved in the prevention and treatment of geriatric diseases, and the overall growth of microorganisms.
7) 제7단계: 제품제조7) Step 7: Manufacture
제4단에서 제조된 홍삼분말발효 60중량%에 제6단계에서 제조된 실크펩타이드 40중량%를 혼합하여 완제품을 생산하였다.60% by weight of the red ginseng powder fermented in the fourth stage was mixed with 40% by weight of the silk peptide prepared in the sixth step to produce a finished product.
완제품을 생산한 다음 항산화활성율을 측정하였다.After producing the finished product, the antioxidant activity was measured.
측정방법How to measure
48-웰플레이트에 브레인호모지네이트(brain homogenate)500mg/ml, 시료물질 10mg, 버퍼 80mg을 넣고 37℃ 수조에서 셰이킹(shaking) 하며, 201nsrks 예비-인큐베이션(pre-incubation) 한 후 100mg Fecl2 를 10mg씩 넣고 다시 37℃에서 30분간 인큐베이션하였다.In a 48-well plate, 500 mg / ml of brain homogenate, 10 mg of sample material, and 80 mg of buffer were shaken in a 37 ° C. water bath, 1001 Fecl 2 after pre-incubation with 201 nsrks. 10mg each was incubated again at 37 ℃ for 30 minutes.
그 다음에 35% HCLO4 100mg씩 넣고 반응을 정지시킨 후 상기플레이트를 3000rpm으로 4℃에서 15분간 원심분리 하였다.Then, 100% of 35% HCLO 4 was added and the reaction was stopped. The plate was centrifuged at 3000 rpm for 15 minutes at 4 ° C.
분리 후 상층액만 취하여 에펜도르튜브(eppendorf-tube) 에 400mg씩 넣고 TBA(50%아세트산중의 500mg/ml)을 200ml씩 넣고 이튜브를 80℃에서 1시간 동안 반응시키고 실온에서 30분간 식힌 후 520nm에서 흡광도를 측정하였다.After separation, only the supernatant was taken, 400 mg each in an eppendorf-tube, 200 ml of TBA (500 mg / ml in 50% acetic acid) was added, the tube was allowed to react at 80 ° C. for 1 hour, and cooled at room temperature for 30 minutes. Absorbance was measured at 520 nm.
또한, TBA반응시 테트라에톡시프로판(tetraethoxypropane)을 이용하여 보정용커브(표준커브)를 구하고 이를 이용하여 반응 후 생성된 MDA의 양을 계산하였다.In addition, a calibration curve (standard curve) was obtained using tetraethoxypropane during the TBA reaction, and the amount of MDA generated after the reaction was calculated.
항산화활성(%) = <(A-B)/A> × 100Antioxidant activity (%) = <(A-B) / A> × 100
<A: MDA의 나노몰수/mg 단백질(아스코르빈산)> <A: nanomolar number of mg / mg protein (ascorbic acid)>
<B: MDA의 나노몰수/mg 단백질(시료물질)><B: nanomolar number of mg / mg protein (sample material)>
그 결과 아스코르빈산의 항산화활성을 100%로 하였을 때의 상대적인 항산화활성이 92%로 측정되어 놀라운 항산화활성율의 결과를 얻었다.As a result, when the ascorbic acid antioxidant activity was 100%, the relative antioxidant activity was measured to be 92%, which resulted in surprising antioxidant activity.
또한, 본 발명의 제품에 대해 당 업계의 10인의 전문가를 무작위 추출하여 관능평가를 실시하였으며, 이를 기존의 홍삼 건강보조식품과 비교하여 5점 비교법으로 평가한 결과 아래와 같은 결과를 얻을 수 있었다.In addition, the sensor of the present invention randomly extracted 10 experts in the industry and carried out a sensory evaluation, and compared with the existing red ginseng health supplements and evaluated by a five-point comparison method, the following results were obtained.
위의 결과를 통해 본 발명의 건강보조식품을 종래의 홍삼 건강보조식품과 비교할 때 향기, 색상, 맛, 전반적인 기호성 등에 있어서 우수한 것을 알 수 있었다.As a result, the health supplement of the present invention was found to be excellent in fragrance, color, taste, overall palatability, and the like as compared with the conventional red ginseng supplement.
88 ) 제8단계: 제품검사Step 8: Product Inspection
국가 및 당사검사의 검사규정에 의하여 생산된 제품을 검사하는 과정을 거치게 된다.The process of inspecting the products produced by the inspection regulations of the state and our inspection.
9) 제9단계: 포장9) Step 9: Packing
당사의 고유의 포장박스에 제품을 넣어 포장하는 과정을 거치게 된다.The product is packaged in our own packaging.
도 1은 본 발명의 실시예에 따른 전체 제조공정도.1 is an overall manufacturing process diagram according to an embodiment of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070094845A KR100917632B1 (en) | 2007-09-18 | 2007-09-18 | Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070094845A KR100917632B1 (en) | 2007-09-18 | 2007-09-18 | Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090029528A true KR20090029528A (en) | 2009-03-23 |
KR100917632B1 KR100917632B1 (en) | 2009-09-24 |
Family
ID=40696229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070094845A KR100917632B1 (en) | 2007-09-18 | 2007-09-18 | Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100917632B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101022174B1 (en) * | 2009-03-18 | 2011-03-17 | 김병도 | Manufacturing method of yeast-complex using animal proteinchicken breast and silk peptide |
KR101119467B1 (en) * | 2009-09-21 | 2012-03-16 | 주식회사 케이티앤지 | Manufacturing method of red ginseng granule |
KR101276994B1 (en) * | 2011-04-05 | 2013-06-27 | (주)대대푸드원 | Manufacturing method of fermentation fisheries using enzyme fermentation zymotechnics |
EP3607836A4 (en) * | 2017-04-07 | 2020-03-25 | CKD Bio Corp. | Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin |
KR20220026230A (en) | 2020-08-25 | 2022-03-04 | 주식회사 굳프렌즈 | Method of Health Assistance Food Mixing Silkpeptide Manufacture and Health Assistance Food Extract using the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100752154B1 (en) * | 2005-07-28 | 2007-08-24 | 주식회사 태영이앤티 | lactic-acid fermented ginseng composite and their manufacturing method |
KR20070121308A (en) * | 2006-06-22 | 2007-12-27 | 구안산업 주식회사 | Lipase inhibitor including processed ginseng, functional food and medical composition including the lipase inhibitor |
KR20080067076A (en) * | 2007-01-15 | 2008-07-18 | 김인상 | The manufacture methods of ginsenocide degradation and it's functional foods |
KR100754276B1 (en) | 2007-02-22 | 2007-09-03 | 김재현 | Nutraceutical with silk peptide and calcium |
-
2007
- 2007-09-18 KR KR1020070094845A patent/KR100917632B1/en not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101022174B1 (en) * | 2009-03-18 | 2011-03-17 | 김병도 | Manufacturing method of yeast-complex using animal proteinchicken breast and silk peptide |
KR101119467B1 (en) * | 2009-09-21 | 2012-03-16 | 주식회사 케이티앤지 | Manufacturing method of red ginseng granule |
KR101276994B1 (en) * | 2011-04-05 | 2013-06-27 | (주)대대푸드원 | Manufacturing method of fermentation fisheries using enzyme fermentation zymotechnics |
EP3607836A4 (en) * | 2017-04-07 | 2020-03-25 | CKD Bio Corp. | Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin |
US11642318B2 (en) | 2017-04-07 | 2023-05-09 | Ckd Bio Corp. | Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin |
KR20220026230A (en) | 2020-08-25 | 2022-03-04 | 주식회사 굳프렌즈 | Method of Health Assistance Food Mixing Silkpeptide Manufacture and Health Assistance Food Extract using the same |
Also Published As
Publication number | Publication date |
---|---|
KR100917632B1 (en) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102356913B (en) | Preparation method of probiotics fermented blueberry pulp powder | |
US8691220B2 (en) | Powdery malted rice extract composition | |
JP2003259835A (en) | Production of fermented product and its utilization | |
CN102318806B (en) | Preparation method of probiotics fermented pumpkin and carrot vegetable powder | |
CN1911118B (en) | Kefir mushroom freeze-dried powder, production method and use thereof | |
CN102919922A (en) | Method for preparing blueberry juice powder fermented by composite probiotics | |
KR100936457B1 (en) | A making method of fermentational composition | |
KR20230037529A (en) | Preparation method of ingredients powder fermented by lactic acid bacteria | |
KR20200076157A (en) | Composition for improving, treating or preventing intestinal function or inflammarory bowel disease comprising fermented rice as an active ingredient | |
KR100917632B1 (en) | Manufacturing method of health assistance food using ginseng steamed red and silk peptide and its health assistance food | |
KR101806720B1 (en) | Antibacterial-listeria composition of culture medium containing membranous milkvetch root fermented with lactobacillus plantarum | |
KR20150105700A (en) | a food additive process using mushroom and containing food additive dough | |
WO2005032568A1 (en) | Immunopotentiator, antiulcer agent and processed foods comprising fermented soybean product and process for producing fermented soybean product | |
JP2010100663A (en) | Enzyme inhibitor containing fermentation product of allium cepa l | |
JP5502449B2 (en) | Intestinal flora balance improving agent and method for producing the same | |
KR101969708B1 (en) | Powder makgeolli composition containing DIY kit type lactic acid bacterium, method of preparing the composition, and makgeolli | |
TWI679982B (en) | Use of lactic acid bacteria fermented material for producing inhibitor of pentosine | |
KR102562888B1 (en) | Preparation method of garlic powder fermented by lactic acid bacteria | |
JP2003047422A (en) | Lactic acid fermented food of whole soybean flour, bean- curd refuse and grifola frondosa, and method for producing the same | |
CN112522053A (en) | Preparation method of acerola cherry fruit wine | |
KR101220815B1 (en) | Manufacturing Method of Fermented Cereals Powder And Fermented Cereals Powder Using The Same | |
KR100963133B1 (en) | Function-related fermentation food using the composition which mixed chlorella in Rubus coreanus and method to produce thereof | |
KR20200058174A (en) | Manufacture method of spirulina extracts | |
KR102607846B1 (en) | Processing method of solid-state fermented red ginseng and white ginseng with enhanced prosapogenin ginsenoside content | |
KR101022174B1 (en) | Manufacturing method of yeast-complex using animal proteinchicken breast and silk peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121122 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130909 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |